ADAT Clinical Sciences Cheat Sheet: 30 High-Yield Decisions

ADAT clinical sciences surprises strong biomedical candidates. The questions are not about reciting a drug class. They are about choosing the next correct step: which anticoagulant to hold, how to sequence perio disease, a failing molar, and a third molar in one chart, which sedation depth to refer, how to stage antiresorptive-related jaw exposure. This cheat sheet condenses thirty high-yield decisions across the eight clusters the ADAT hits hardest.

Start with the free Lumen ADAT diagnostic for a calibrated baseline.

What ADAT Clinical Sciences Actually Tests

Clinical sciences rewards three things: judgement under uncertainty, correct sequencing of multi-step care, and safe management of the medically complex patient. Items open with a short vignette, present findings that narrow the differential, and ask for the next best step rather than the diagnosis. The trap is choosing the most aggressive intervention when the question is testing whether you recognize that conservative management is correct first.

Three patterns recur: the medically complex patient whose medication changes the plan; the multi-quadrant case where one phase must precede another; the acute presentation where prioritization beats comprehensiveness.

Anticoagulation Management for Dental Procedures

The dominant question is whether to interrupt therapy before an invasive procedure. The contemporary standard, supported by ACC, ADA, and most thrombosis consensus statements, is that routine dental surgery does not require interruption of therapeutic anticoagulation in most patients. Bleeding risk is local and manageable; thromboembolic risk of stopping is systemic and serious.

Drug or class	Management	Reversal
Warfarin, INR <= 3.5	Proceed with local hemostasis; do not interrupt	Vitamin K, PCC, or FFP if bleeding
Warfarin, INR > 3.5	Defer elective surgery; consult prescriber	As above
DOACs (apixaban, rivaroxaban, dabigatran, edoxaban), routine extractions	Proceed without interruption; morning, hemostasis kit	Idarucizumab (dabigatran); andexanet alfa (Xa inhibitors)
DOACs, multiple extractions, flaps, implants with grafting	Consider skipping morning dose only; never bridge	As above
Aspirin monotherapy	Do not interrupt	Local measures
Dual antiplatelet therapy, routine extractions	Do not interrupt; coordinate with cardiology if recent stent	Platelets for life-threatening bleed
LMWH (prophylactic)	Proceed with local hemostasis	Protamine (partial)

Local hemostasis means oxidized cellulose or gelatin sponge in the socket, figure-of-eight suture, tranexamic acid mouthwash for two days, and explicit post-op instructions. The exam rewards choosing local measures and proceeding, not reflexively stopping the anticoagulant.

The most testable trap is DAPT after recent drug-eluting stent placement. Stopping clopidogrel or ticagrelor in the first six to twelve months carries real stent thrombosis risk. Defer elective surgery until the DAPT window closes, or proceed with local measures and cardiology coordination for urgent care.

MRONJ: AAOMS Staging and Management

The AAOMS 2022 position paper formalized staging the ADAT can test directly. Diagnostic criteria: current or previous antiresorptive or antiangiogenic therapy; exposed bone or bone probeable through a maxillofacial fistula persisting more than eight weeks; no head and neck radiation or obvious metastatic disease.

Stage	Findings	Management
0	No exposed bone; non-specific symptoms or radiographic changes	Symptomatic care, antibiotics if indicated, observation
1	Exposed bone, asymptomatic, no infection	Chlorhexidine 0.12% rinse, quarterly follow-up
2	Exposed bone with infection (pain, erythema, purulence)	Rinse, oral antibiotics (penicillin VK or clindamycin), pain control, superficial debridement
3	Stage 2 plus pathologic fracture, extraoral fistula, oroantral or oronasal communication, or osteolysis to inferior border or sinus floor	Antibiotics, surgical debridement or resection, OMS referral

Prevention: complete elective dentoalveolar surgery before high-risk antiresorptive therapy starts when possible. Risk depends on indication (oncologic doses far higher than osteoporosis), duration (greater than four years on oral bisphosphonates is the historical threshold), and route (IV nitrogen-containing bisphosphonates and denosumab carry highest risk). Drug holidays are decided with the prescriber.

Treatment Planning Sequencing

The ADAT loves multi-quadrant cases that test phasing. Stefanac's framework sequences care in the order that holds biologically and prosthetically: acute, preventive, disease control, definitive, maintenance.

1. Acute or systemic. Pain, acute infection, life-threatening findings. Drain abscesses, manage trauma, refer suspicious lesions for biopsy.
2. Preventive. Caries risk assessment, hygiene instruction, fluoride and remineralization, dietary counseling, smoking cessation. Skipping prevention guarantees later restorative failure.
3. Disease control. Caries excavation with provisionals, scaling and root planing, endodontics on restorable teeth, extraction of hopeless teeth. Stabilize biology before committing to prosthetics.
4. Definitive restorative and prosthetic. Direct and indirect restorations, fixed and removable prosthodontics, implant-supported restorations. Begins only after periodontal stability and endodontic completion.
5. Maintenance. Scheduled recall, periodontal maintenance intervals appropriate to risk.

The most common trap is choosing definitive restorative options for a patient with active periodontitis or unrestored caries. Place periodontal therapy first, reassess, then proceed with crowns, bridges, or implants.

Medically Complex Patient Quick Decisions

• Hypertension. BP > 180/110 defers elective care. Above 160/100, limit elective care, consider stress reduction. Below 160/100, proceed routinely with epinephrine at conventional doses.
• Diabetes. HbA1c above 8% raises infection and healing risk; coordinate with physician for elective surgery. Glucose < 70 mg/dL is hypoglycemia, treat first. Morning appointments after a normal meal are safest.
• ESRD on hemodialysis. Schedule the day after dialysis. Avoid NSAIDs. Adjust antibiotic and analgesic doses to renal function.
• Pregnancy. Second trimester is safest for elective care. Avoid tetracyclines and first-trimester metronidazole. Local anesthetic with epinephrine at conventional doses is safe.
• Recent MI. Defer elective care at least four weeks; six months is the historical conservative threshold. Urgent care proceeds with stress reduction and physician coordination.
• IE prophylaxis. Reserved for highest-risk cardiac conditions: prosthetic valve, prior IE, certain congenital heart disease, transplant with valvulopathy. Amoxicillin 2 g PO one hour before; cephalexin or clindamycin for allergy.
• Prosthetic joints. Routine prophylaxis no longer recommended for most patients. Coordinate with orthopedics for the rare immunocompromised or recently operated case.

Pattern: treat the medical condition as a modifier of the dental plan, not an automatic contraindication.

TMD: Differential and Conservative First-Line

The differential separates myofascial pain, disc displacement (with and without reduction), degenerative joint disease, and inflammatory joint disease.

First-line for most TMD is conservative and reversible: parafunction education, soft diet, moist heat, jaw rest, NSAIDs, and a flat-plane stabilization splint. Aggressive interventions (occlusal adjustment, full-mouth rehab for TMD, surgery) are reserved for refractory or specifically indicated cases. A question offering equilibration as first-line for myofascial pain is testing whether you choose the splint.

Red flags warranting urgent imaging and referral: unilateral preauricular swelling with fever (septic arthritis), trismus preventing oral intake, neurologic deficits, history of head and neck malignancy.

Sedation Levels and Reversal

The ADA defines four levels the ADAT can ask you to identify and manage if a patient drifts deeper than intended.

• Minimal (anxiolysis). Normal response to verbal commands. Ventilation and cardiovascular function unaffected. Typical agent: nitrous oxide.
• Moderate (conscious sedation). Purposeful response to verbal or tactile stimulation. Airway patent, ventilation adequate. Typical agents: oral, IV, or combination benzodiazepine and opioid.
• Deep. Not easily aroused, responds purposefully to repeated or painful stimulation. Airway intervention may be required.
• General anesthesia. Not arousable; often requires airway and ventilatory support.

Sedation is a continuum and the practitioner must be qualified to rescue from one level deeper than intended. A dentist providing moderate sedation must be able to manage deep sedation, including airway support.

Reversal: flumazenil reverses benzodiazepine oversedation at 0.2 mg IV, repeated as needed. Naloxone reverses opioid oversedation at 0.04 to 0.4 mg IV titrated to respiratory rate. Both are short-acting; monitor for re-sedation.

Restorative and Endodontic Decision Points

A tooth is generally restorable when adequate ferrule (1.5 to 2 mm circumferentially) can be established, periodontal attachment is sufficient, and crown-to-root ratio is acceptable. It is endodontically treatable when canals are negotiable, the periapical lesion can heal, and medical status permits. Failing either test, the tooth is often better extracted with an implant or FPD plan, particularly in posterior occlusion-bearing positions.

Pulpal diagnosis: reversible pulpitis (sharp pain to cold, dissipates rapidly, no spontaneous pain) — remove the irritant. Symptomatic irreversible pulpitis (lingering, often spontaneous pain) — pulpectomy or extraction. Pulpal necrosis (no thermal response, may have apical findings) — RCT or extraction.

Five Sample MCQs

1. A 68-year-old on apixaban 5 mg BID for atrial fibrillation needs extraction of a non-restorable mandibular first molar. Next best step:

A. Hold apixaban for 48 hours. B. Bridge with LMWH. C. Schedule morning, do not interrupt apixaban, use local hemostatic measures, and provide tranexamic acid mouthwash. D. Defer until apixaban is replaced with warfarin.

2. A 74-year-old on monthly IV zoledronic acid for two years presents with 4 mm of exposed necrotic mandibular bone, painful, with erythema and purulent drainage. No fistula or fracture. AAOMS stage and management:

A. Stage 1; chlorhexidine and observation. B. Stage 2; oral antibiotics, antimicrobial rinse, pain control, superficial debridement. C. Stage 3; segmental mandibulectomy. D. Stage 0; symptomatic care only.

3. New patient: generalized severe periodontitis, two carious lesions, asymptomatic apical radiolucency on tooth 19, chief complaint of wanting an implant at site 30. Which phase first after acute care?

A. Implant placement at 30. B. Crown on 19. C. Scaling and root planing with reassessment. D. Full-mouth rehabilitation.

4. A patient on moderate IV sedation with midazolam and fentanyl becomes unresponsive, RR 6, SpO2 88%. Most appropriate sequence:

A. Flumazenil 0.2 mg IV and continue. B. Open airway, positive pressure ventilation with supplemental oxygen, naloxone 0.04 to 0.4 mg IV titrated to effect, consider flumazenil, activate emergency response. C. Naloxone 2 mg IV bolus and observe. D. Discontinue monitoring and transport.

5. A 32-year-old reports six weeks of bilateral preauricular pain worse on chewing, morning stiffness, and a right-side click that reduces with opening. No swelling, fever, or neurologic deficit. First-line management:

A. Bilateral TMJ arthroscopy. B. Full-mouth occlusal equilibration. C. Education, soft diet, NSAIDs, and a flat-plane stabilization splint. D. Long-term opioid analgesia.

Answers. 1: C — routine extraction does not require DOAC interruption. 2: B — necrotic bone with infection, no stage 3 features. 3: C — periodontal control precedes definitive restorative or implant work. 4: B — airway, breathing, oxygenation first; reverse the likely agent. 5: C — conservative reversible therapy first-line for TMD without red flags.

Where Lumen Fits

Lumen maintains a clinical sciences question bank mapped to the ADA ADAT content outline, with weighted attention to anticoagulation, MRONJ, sequencing, sedation safety, and the medically complex patient. The biomedical bank is included for sequencing INBDE prep into ADAT prep. Pricing is on our pricing page. Broader context lives across the Lumen blog, including ADAT vs INBDE, the ADAT biomedical high-yield guide, and our dental pharmacology mnemonics. The ADAT exam overview covers registration, blueprint, and timeline.

Start the free Lumen ADAT diagnostic to find out which clusters need a focused four to six week build before your application window opens.

FAQ

What's tested on ADAT clinical? Judgement, sequencing, and safe management of the medically complex patient. High-yield clusters: anticoagulation, MRONJ staging, treatment planning sequencing (acute, preventive, disease control, definitive, maintenance), TMD differential and conservative management, sedation levels and reversal, restorability and pulpal diagnosis, and medical-modification rules for hypertension, diabetes, renal disease, pregnancy, and post-MI care.

What is the hardest ADAT topic? Medically complex patient management is hardest because items integrate pharmacology, internal medicine thresholds, and procedural judgement in one vignette. Treatment planning sequencing is second hardest because the trap answer is almost always plausible. Anticoagulation is the highest-frequency cluster and should be locked down early.

How should I study ADAT clinical? Start with a calibrated diagnostic to find weak clusters. Build a six to ten week plan allocating time proportional to weakness and blueprint weight, with a daily mixed question block forcing clinical reasoning rather than rote recall. Use Stefanac for sequencing, the AAOMS 2022 position paper for MRONJ, Newman and Carranza for periodontal sequencing, and Misch for implants. Finish with at least two timed full-length tests at exam pacing.

Do I need to memorize specific INR thresholds? Yes. INR <= 3.5 is the contemporary threshold for proceeding with routine dental surgery on warfarin without interruption. The principle (local hemostatic measures first) matters more than the precise number, but examiners test the threshold itself.

Is DAPT a reason to stop medication before extraction? No, in most cases. Routine extractions proceed under DAPT with local hemostasis. Exception: the first six to twelve months after drug-eluting stent placement, where stopping P2Y12 inhibitors carries real stent thrombosis risk. Coordinate with cardiology rather than stopping unilaterally.

How is MRONJ stage 0 different from stage 1? Stage 0: no exposed bone but non-specific symptoms or radiographic changes in a patient with appropriate medication history. Stage 1: exposed or probeable bone but asymptomatic and uninfected. Stage 0 is observed; stage 1 adds an antimicrobial rinse and quarterly follow-up.

When is occlusal equilibration first-line for TMD? Almost never. Conservative reversible therapy (education, soft diet, NSAIDs, flat-plane stabilization splint) is first-line for the vast majority of TMD presentations.